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Abstract
Introduction. Carriers of reciprocal (RCP) and Robertsonian (RT) translocations are known to be at risk for 
reproductive difficulties. Preimplantation genetic diagnosis (PGD) is one of the options these carriers have to try 
to fulfill their desire to have a child. The FISH technique is one of the best method to detect RCPs, and, together 
with the Next Generation Sequencing, to diagnose RTs. The aim of the present study was to assess the usefulness 
of the FISH method for rapid diagnosis of translocations in our center to improve the reproductive counseling. 
Material and methods. From 2008 to 2012 one hundred and twenty seven fresh cycles of the in vitro fertilization 
(IVF; without freezing embryos) were performed in 42 couples with an RCP and 35 couples with an RT trans-
locations. The patients were diagnosed before IVF as translocation carriers and therefore they opted for PGD. 
The classical FISH protocol has been applied with specific oligonucleotide probes.
Results. In total 521 blastomeres were tested in order to determine the presence or absence of genetic anomalies 
resulting from one of the parents being a translocation carrier. Despite the large number of abnormal embryos 
(407 embryos — 78.1% of all examined embryos), 19.4% of blastomeres appeared to come from a normal or 
balanced embryos that may have been transferred to the uterus. In 63 of the 127 cycles embryo transfer (ET) 
was feasible and 24 women had a successful singleton or twin pregnancy. Thus, a live delivery rate of 18.9% per 
started cycles and 38.1% per cycle with ET was obtained. 
Conclusion. FISH should be regarded as an optimal preimplantation genetic diagnosis method for specific 
RCP and RT translocation carriers to increase the chance of successful IVF procedure. (Folia Histochemica 
et Cytobiologica 2015, Vol. 53, No. 2, 162–168)
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Introduction
Difficulties associated with conception are an impor-
tant and common problem of the modern world. It is 
estimated that it affects approximately 15% of couples 
in reproductive age. About 35% of the issues involved 
with infertility are due to the man, another 30% due to 
the woman, and 10% result from complications associ-
ated with both partners [1]. There are many causes of 
infertility, however, approximately 30% of cases are as-
sociated with genetic factors such as translocations [2].
Balanced chromosomal translocations involve 
breaks in two chromosomes and abnormal repair of 
the chromosomal fragments resulting in the trans-
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position of genetic material from one chromosome 
to another one without loss of any genetic material. 
Carriers of balanced translocations are phenotypically 
normal, unless one of the translocation breakpoints 
interrupts an important gene or position effects take 
place. It has been estimated that 1 in 625 individuals 
carries a balanced chromosomal translocation [3]. Even 
phenotypically normal carriers of balanced chromo-
somal translocations may experience reduced fertility, 
spontaneous abortions or birth defects [4]. In couples 
suffering from recurrent miscarriage, the incidence of 
the couple being a carrier of a structural chromosome 
abnormality is approximately 4–5%, mainly including 
reciprocal (RCP) and Robertsonian (RT) transloca-
tions [5]. Reduced fertility in translocation carriers 
may in part be the result of formation of a quadrivalent 
or trivalent structure (RCP and RT translocations, 
respectively) during meiosis what enables homologous 
chromosomes to pair. Theoretically, chance of pro-
ducing normal or balanced gametes is 4:32 for RCP 
translocation, and 4:16 for RT translocations. However, 
the actual percentage depends on several factors, in-
cluding chromosomes involved, the breakpoints, and 
carrier’s gender [6, 7]. It should be noted that levels of 
unbalanced gametes will be significantly higher than the 
empiric risk of having a chromosomally unbalanced live 
birth. This is due to the fact that many, if not most, of 
the segregate products, will be spontaneously aborted 
early in development (depending on the chromosomes 
and size of the segment involved) [4, 8].
Preimplantation genetic diagnosis (PGD) is an 
option for couples carrying balanced translocations. 
Fluorescence in situ hybridization (FISH) allows for 
analysis of metaphase nucleus from biopsied embryos. 
However, the number of chromosomes studied by 
FISH is limited to the number of chromosome-speciﬁc 
probes available. The strategy of FISH analysis de-
pends on chromosomes involved in the structural 
rearrangement and the size of the translocated seg-
ment, and usually involves a combination of the lo-
cus-speciﬁc, centromeric, and/or subtelomeric probes. 
The aim of the present study was to use the FISH 
method for rapid diagnosis of translocations during in 
vitro fertilization (IVF) fresh cycle (without freezing 
embryos). We retrospectively analyzed the results of 
5 years (2008–2012) of PGD for RCP and RT carriers 
to improve the reproductive counseling.
Material and methods
Patients. The study protocol was approved by the Insti-
tutional Review Board and written informed consent was 
given by each couple participating in PGD. During medical 
and genetic counseling, the procedure, the genetic risk of 
chromosome translocation, an advantages and limitations 
of PGD were explained to the couples. The risk of mis - 
diagnosis attributable to embryonic mosaicism and the 1–2% 
technical error rate of the FISH procedure used in PGD 
were also detailed. 
The retrospective analysis included 42 couples who were 
RCP and 35 couples who were RT carriers. Participants 
underwent 127 PGD cycles between September 2008 and 
May 2012. Parental age, type of translocation, family and 
reproductive history were recorded.
Oocyte retrieval, assessment of fertilization and embryo 
development. All PGD couples underwent IVF procedure 
after stimulation using long-term protocol of pituitary de-
sensitization with the GnRH agonist (Diphereline 0.1 mg/d; 
Pharmacia Upjohn, Kalamazoo, MI), starting on day 14 of 
the oral contraception cycle as described previously [9]. The 
oocyte retrieval procedure was performed 35 hours after 
administration of human chorionic gonadotropin (hCG; 
Ovitrelle, Merck Serono S.p.A., Modugno, Italy), under 
the control of transvaginal ultrasound. Retrieved oocytes 
were fertilized by intracytoplasmic sperm injection (ICSI) 
and checked daily for the presence of pronuclei and polar 
bodies. Fertilized embryos were cultured in G1 medium 
(Vitrolife, Västra Frölunda, Sweden) at 37°C under the 
atmosphere of 6% CO2 and 5% O2 in air for 3 days. Embryo 
development was assessed daily and embryos that reached 
the 6–8-cell stage, were equal in size and had fewer than 
30% of fragmentation, were biopsied on day 3. 
Embryo biopsy and blastomere fixation for FISH. For biop-
sy, embryos were incubated in G1 medium. Perforation in 
the zona pellucida membrane has been done by chemical 
method using Tyrode’s solution. A single blastomere was 
taken from each embryo. After biopsy, the embryo was 
washed, transferred to G2 medium (Vitrolife, Västra Frölun-
da, Sweden) and cultured for the next two days. Aspirated 
blastomere samples were prepared as described by Coonen 
et al. [10]. Briefly, samples were lysed in hypotonic buffer 
for 1–2 minutes. The cell nuclei were separated and fixed 
on glass slides using 0.01N HCl/0.1% Tween20. The slides 
were air-dried, washed with PBS for 5 min and dehydrated in 
a series of 70%, 80%, 100% ethanol solutions before FISH. 
Fluorescent in situ hybridization. The FISH probes used 
included locus-specific (LSI; Interphase FISH LSI®-Fu-
sion Probe; Abbott Molecular, Des Plaines, IL, USA) and 
subtelomeric regions probes (TelVysion probes; Abbott 
Molecular; Kreatech™ FISH probes, Kreatech Diagnostics, 
Amsterdam, The Netherlands), specific for investigated 
chromosomes and labeled with different colors. The spe-
cificity and sensitivity of the probes had been previously 
tested using patients’ lymphocytes’ cultures. All probes had 
specificities of 100% and efficiencies of 84–95% [11].
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Mixtures of the oligonucleotide probes were prepared 
according to the manufacturer’s protocol. The nuclei and 
probes were combined on the glass slides and denaturized 
by heating to 73°C. The slides were incubated in the humid-
ified chamber at 37°C and the results were assessed on the 
next day. In urgent situations, our modified short protocol 
with 4 hour hybridization at 73°C was used which allowed 
the material to be analyzed in only one day. The slides were 
analyzed using a fluorescence microscope (Olympus BX61, 
Olympus, Tokyo, Japan) and images were captured using 
camera (F view, Olympus). Blastomeres presenting two 
signals for each probe were classified as normal or balanced, 
while any other combination was classified as unbalanced. 
FISH signals were independently scored and interpreted 
by two observers.
Embryo transfer and pregnancy evaluation. Embryos with 
normal and balanced FISH signals were transferred into the 
uterine cavity on the 5th day after oocyte retrieval. Serum 
b-hCG concentration was measured 3, 6 and 10 days after 
transfer. Clinical pregnancy was defined as the presence of 
a fetal heartbeat on vaginal ultrasonography at 4–5 weeks 
after embryo transfer. The fertilization rate was defined as 
the proportion of fertilized oocytes compared to the number 
of all cells undergoing fertilization. The implantation rate 
was defined as the percentage of embryos which successfully 
undergo implantation compared to the number of embryos 
transferred in a given time period. Cancellation rate was 
defined as the number of cancelled cycles compered to all 
cycles. Miscarriage rate was defined as the percentage of 
spontaneous abortions which occur up to 12 weeks of preg-
nancy and the number of pregnancies. Live birth rate was 
defined as the percentage of all cycles that lead to live birth. 
Statistical analysis. Data comparisons were made using 
chi-square test. All statistical analyses were performed using 
STATISTICA data analysis software system, version 10 
(StatSoft Inc., Tulsa, OK, USA). Statistical significance was 
defined as p < 0.05.
Results
The characteristics and clinical outcomes of the PGD 
cycles conducted in RCP and RT carriers are sum-
marized in Table 1. During the 5-year time period, 
127 cycles of PGD were performed in 42 couples 
with RCP, including 25 female (the mean age 32.3 ± 
3.72; range 25–41 years) and 17 male carriers (the 
Table 1. Patients’ characteristics and PGD outcomes of investigated couples
Reciprocal  
translocation
Robertsonian  
translocation
Total
Average age of women (mean ± SEM) 32.3 ± 3.72 y 33.9 ± 3.64 y
Average age of men (mean ± SEM) 35.2 ± 5.03 y 35.5 ± 3.89 y
Number of couples 42 35 77
Number of male/female carriers 17/25 21/14 38/39
Number of cycles 64 63 127
Number of retrieved oocytes 585 494 1079
Number of 2PNa embryos 414 330 744
Fertilization rate (%) 70.8 66.8 68.9
Number of biopsied embryos 328 220 548
Number of analyzed blastomeres 310 211 521
Number of normal or balanced embryos 48 53 101
Proportion of normal or balanced embryos to all embryos (%) 15.5 25.1 19.4
Number of embryo transfers (ETb) 31 32 63
Implantation rate (%) 34.5 41.2 38.7
Cancellation rate (%) 64.1 61.9 63.1
Number of clinical pregnancies 10 14 24
Clinical pregnancy rate per ETb (%) 32.3 43.7 38.1
Miscarriage rate (%) 10 7.1 8.3
Live birth rate per couple (%) 21.4 37.1 28.6
aPN — pronuclei; bET — embryo transfer
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Figure 1. Blastomeres from two embryos of one couple analyzed by FISH probes specific for chromosomes 4 and 7.  
CEP7 (Spectrum Aqua) for centromere, 4p (Spectrum Green) and 7p (Spectrum Red) for appropriate telomeric regions.  
A. Genetically balanced (or normal) blastomere: nuc ish (CEP 7p11.1-q11.1x2) (4p02x2) (ST7pterx2); embryo was used  
for embryonic transfer; B. Genetically incorrect blastomere: nuc ish (CEP 7p11.1-q11.1x1) (4p02x2) (ST7pterx1);  
embryo was excluded from the embryonic transfer
A B
Figure 2. Blastomeres from two embryos of one couple analyzed by FISH probes specific for chromosomes 4 and 10.  
CEP 10 (Spectrum Aqua) for centromere, 10p (Spectrum Green) and 4q (Spectrum Orange) for appropriate telomeric 
regions. A. Genetically balanced (or normal) blastomere: nuc ish (CEP 10p11.1-q11.1x2) (4q D4S2930x2)  
(10p TEL006x2); embryo was used for embryonic transfer; B. Genetically incorrect blastomere: nuc ish  
(CEP 10p11.1-q11.1x3) (4q D4S2930x1) (10p TEL006x4); embryo was excluded from for embryonic transfer
A B
mean age 35.2 ± 5.03; range 27–48 years), and in 
35 couples with RT, including 14 female (the mean age 
33.9 ± 3.64; range 22–42 years) and 21 male carriers 
(the mean age 35.5 ± 3.89; range 28–45 years). 
The mean number of oocytes aspirated from the 
77 couples, including couples with either a male or 
female RCP and RT carriers, was 11.7 per cycle. 
The percentage of fertilized embryos reached a de-
velopmental stage that permitted successful biopsy 
was 79.2% and 66.7% for RCP and RT translocation 
carriers, respectively. Out of the 521 blastomeres 
tested, only 101 (19.4%) were normal or balanced 
(Fig. 1A; 2A), 407 (78.1%) were abnormal (Fig. 1B; 
2B) and 13 (2.5%) yielded inconclusive results. The 
fertilization rate was 70.8% for RCP and 66.8% for 
RT translocation carriers but proportion of normal 
or balanced embryos differed significantly and was 
higher in the RCP group (p < 0.05).
The number of clinical pregnancies determined 
by serum hCG levels and embryo’s heart beats in 
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the 5–6th week was 26 (41.3%), out of 63 cycles of 
embryo transfer; however, two pregnancies were 
spontaneously terminated at 9 and 11 weeks of 
gestation.
No differences were evident during pregnancy and 
after delivery what was ascertained by the medical 
records. 
Discussion
We present here for the first time the Polish expe-
rience on embryo-PGD use for rapid detection of 
RCP and RT translocations during IVF fresh cycle 
(without freezing embryos). Retrospective analysis 
of results obtained during 5 years revealed satisfying 
fertilization rate (68.9%) after exchange of genetic 
material derived from RCP and RT translocations 
carriers. With the use of FISH technique, we also 
identified and excluded 78.1% of abnormal embryos 
which can occur in couples who are carriers of chro-
mosomal aberrations. This result is in agreement 
with the worldwide data which presents high rates of 
unbalanced embryos detected during PGD of RCP 
[12–16] and RT translocations [12–17]. 
In our study, the number of retrieved oocytes 
and the fertilization rate did not differ between RCP 
and RT couples. However, proportion of normal or 
balanced embryos to all embryos analyzed differed 
significantly between analyzed groups. American 
Preimplantation Genetic Diagnosis Special Interest 
Group have published similar results regarding rates 
of unbalanced embryos distinguished between RCP 
and RT translocations carriers, where they observed 
more pregnancies in favor of patients with RT translo-
cations [13, 15, 16, 18–21]. However, it has to be noted 
that other authors did not observed such discrepancies 
[14, 22]. These differences may result from application 
of divergent sets of FISH probes [14] or distinct timing 
of blastomere biopsy [14, 20] as the number of cells in 
the embryo is growing and the abnormality rate may 
change depending on the time of the day [20].
In both types of translocations analyzed in this 
study, we found high number of embryos which were 
suitable for blastomere biopsy, which is in agreement 
with other studies [11, 22]. In view of poorer assisted 
reproductive technology outcome in RCP and RT 
patients and slower growth profile of the embryos 
obtained from the translocation carriers [20], the 
number of biopsy acceptable embryos seems to be 
satisfying. However, we observed low percentage of 
transferable embryos (19.4%), which confirms ob-
servations of other authors [7, 14, 16, 22]. Moreover, 
the European Society for Human Reproduction and 
Embryology (ESHRE) PGD Consortium released 
data collection X (2010) where they detailed the PGD 
results of 57 participating centers [23]. Considering 
oocytes that were successfully fertilized, biopsied and 
gave a successful diagnostic results (n = 53,652), the 
average of transferable embryos (normal/balanced) 
was only 26% (938/3,652) [23]. These data sets clearly 
provide compelling evidence that carriers of structural 
chromosomal rearrangements produce chromo-
somally unbalanced gametes, capable of fertiliza-
tion. Indeed, the risk of having unbalanced sperm is 
7–16% [12, 24–26] and the risk of having unbalanced 
oocytes 32–36% [13, 27] in transformation carriers as 
demonstrated by FISH method, reflecting higher ma-
ternal impact on the embryo [16, 22]. Combined with 
factors such as maternal age [28], abnormal embryo 
morphology [20, 29], lack of cell cycle check-points 
in the early embryonic mitotic divisions [30], all this 
issues cumulate and result in very high proportion of 
aneuploid embryos.
Clinical pregnancy rate in our study, in a group of 
patients who are < 35, is at the similar level (38.1%) 
as the clinical pregnancy rate reported by other 
authors (35.9% by Lim et al. [14]; 39% by Fischer 
et al. [15]). We also observed spontaneous abortion 
incidents. In contrast to other investigators [14], we 
did not perform the cytogenetic analysis of aborted 
 tissue. It is common to observed mosaic embryos in 
translocation carriers [30–33]. Tetraploid FISH signal 
can be also visualized in unbalanced embryo [31, 32, 34]. 
Patients who are translocations carriers also suffer 
from antiphospholipid syndrome, luteal phase defi-
ciency, factor V Leiden heterozygosity and Crohn’s 
disease [33]. Thus, in the case of miscarriage which 
happened despite PGD, occurrence of unbalanced 
form of chromosomal aberration or parental effect 
cannot be ruled out. 
IVF, when combined with PGD for structural rear-
rangements, is characterized by a very high probability 
of achieving a viable embryo and unaffected pregnan-
cy. Close to a sevenfold reduction in pregnancy loss 
rate was obtained in translocation carriers couples who 
afforded PGD [15]. On the other hand, Franssen et al. [36] 
performed a systematic review of the published data 
and found that after natural conception, live birth rate 
per couple varied between 33% and 60% (median 
55%). After PGD, live birth rate per couple varied 
between 0 and 100% (median 31%). Thus, PGD 
improves the live birth rate in couples with recur-
rent miscarriage [4, 7, 18, 22] but for those carrying 
a structural chromosome abnormality, its efficiency 
still seems to be insufficient [36]. However, for couples 
who are carriers of translocations with increased risk 
of chromosomally unbalanced offspring and increased 
risk of recurrent miscarriages, the PGD is still a chance 
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to exclude misdiagnosis and to choose the embryo that 
could be transferred preferentially [12].
FISH technique is a relatively good method of 
pre-implantation diagnosis of RCP and RT transloca-
tions. However, there are other possible approaches 
to RT translocation such as a multiplex ﬂuorescent 
PCR using polymorphic microsatellite markers for 
the detection of numerical changes in chromosomes 
using their allelic ﬁngerprints and Next Generation 
Sequencing (NGS). In the case of diagnostics of RCP 
translocations, progress was also reported in the de-
velopment of single-cell comparative genome hybrid-
ization (CGH) technique and microarrays to enable 
PCR-based testing for translocations. However, the 
most important limitation of the present CGH pro-
tocol is still the three-day duration of the procedure, 
which is incompatible with the current laboratory 
framework for PGD. Therefore, for the moment, the 
best currently used method for the diagnosis of RCP 
translocation during IVF cycle is FISH.
In line with previously published PGD series de-
scribing application of FISH method for rapid diag-
nosis of translocations, we showed that this technique 
has a great potential to be a useful tool for embryos 
selection, especially in couples being a carriers of RCP 
and RT translocations or in improving reproductive 
counseling in couples with recurrent miscarriages. 
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